Pipeline
Explore our diverse dermatology assets, dynamic companies, and dedicated innovation resources — an unrivaled portfolio of sustainable innovations that start with skin, then reimagine the possibilities for patient care.
Our leading breakthroughs
At the forefront of our pipeline, Blossom Innovation and our companies are pursuing the development of multiple clinical-stage and pre-commercial dermatology assets.
R2 Technologies
Proprietary controlled
cooling platform
Contact system for benign skin lesions
Robotic spray system for skin lightening
AVAVA, Inc.
Next-gen 3D precision
laser platform
Melasma/Post-inflammatory
hyperpigmentation (PIH)
Rejuvenating skin of color
S3Inject
Injection targeting system
Aesthetic injectables
Medical injectables
Vascular access
- Independent companies
- Blossom Innovation assets
Our leading breakthroughs
At the forefront of our pipeline, Blossom Innovation and our companies are pursuing the development of multiple clinical-stage and pre-commercial dermatology assets.
- Independent companies
- Blossom Innovation assets
R2 Dermatology
Proprietary controlled cooling platform
Contact system for benign skin lesions
Robotic spray system for skin lightening
AVAVA, Inc.
Next-gen 3D precision laser platform
Melasma/Post-inflammatory hyperpigmentation (PIH)
Rejuvenating skin of color
S3Inject
Injection targeting system
Aesthetic injectables
Medical injectables
Vascular access
Explore our companies & assets
Our most advanced therapies and technologies have transformative potential in dermatology. They’re currently being developed by Blossom Innovations companies with dedicated expertise in commercializing innovations in skin health.
Our Innovation Studio
Discover the unique team of interdisciplinary experts who create our extraordinary new clinical solutions to patients’ unmet needs.
Our science starts with skin. Our vision reimagines patient care.
Beyond our current focus in dermatology, our pipeline has an extended roadmap with truly disruptive potential. Contact us to learn more.
